|
UBE2CP3
|
CD31 mRNA
|
---|
Low(n)
|
High(n)
|
P
|
Low(n)
|
High(n)
|
P
|
---|
All cases
|
22
|
24
| |
29
|
17
| |
Age(year)
|
>=55
|
13
|
14
|
0.958
|
17
|
10
|
0.989
|
<55
|
9
|
10
| |
12
|
7
| |
Sex
|
Male
|
16
|
20
|
0.384
|
21
|
15
|
0.376
|
Female
|
6
|
4
| |
8
|
2
| |
Edmondson grade
|
I~II
|
14
|
12
|
0.351
|
15
|
11
|
0.391
|
III~IV
|
8
|
12
| |
14
|
6
| |
Tumor invasion
|
T1~T2
|
14
|
7
|
0.019*
|
16
|
5
|
0.090
|
T3~T4
|
8
|
17
| |
13
|
12
| |
Cirrhosis
|
Without
|
13
|
12
|
0.536
|
18
|
7
|
0.170
|
With
|
9
|
12
| |
11
|
10
| |
Tumor number
|
Single
|
21
|
16
|
0.014*
|
27
|
10
|
0.015*
|
Multiple
|
1
|
8
| |
2
|
7
| |
Tumor size,cm
|
<=10
|
15
|
11
|
0.127
|
20
|
6
|
0.026*
|
>10
|
7
|
13
| |
9
|
11
| |
- The median expression level was used as the cut off. Low expression of UBE2CP3 in 22 patients was classified as values below the 50th percentile. High UBE2CP3 expression in 24 patients was classified as values at or above the 50th percentile.
- Abbreviations: EV endothelial vessel, UBE2CP3 ubiquitin conjugating enzyme E2 C pseudogene 3. *P < 0.05, ** P < 0.01